GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » EV-to-FCF

Abingdon Health (Abingdon Health) EV-to-FCF : -5.48 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Abingdon Health's Enterprise Value is $16.44 Mil. Abingdon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.00 Mil. Therefore, Abingdon Health's EV-to-FCF for today is -5.48.

The historical rank and industry rank for Abingdon Health's EV-to-FCF or its related term are showing as below:

ABDXF' s EV-to-FCF Range Over the Past 10 Years
Min: -7.38   Med: -1.36   Max: 232.95
Current: -5.33

During the past 6 years, the highest EV-to-FCF of Abingdon Health was 232.95. The lowest was -7.38. And the median was -1.36.

ABDXF's EV-to-FCF is ranked worse than
100% of 94 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.03 vs ABDXF: -5.33

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Abingdon Health's stock price is $0.07. Abingdon Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.009. Therefore, Abingdon Health's PE Ratio for today is At Loss.


Abingdon Health EV-to-FCF Historical Data

The historical data trend for Abingdon Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health EV-to-FCF Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-FCF
Get a 7-Day Free Trial - - -2.16 -1.44 16.39

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only - -1.44 - 16.39 -

Competitive Comparison of Abingdon Health's EV-to-FCF

For the Diagnostics & Research subindustry, Abingdon Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Abingdon Health's EV-to-FCF falls into.



Abingdon Health EV-to-FCF Calculation

Abingdon Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=16.436/-2.999
=-5.48

Abingdon Health's current Enterprise Value is $16.44 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health  (OTCPK:ABDXF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Abingdon Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.07/-0.009
=At Loss

Abingdon Health's share price for today is $0.07.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.009.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Abingdon Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Abingdon Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (Abingdon Health) Business Description

Traded in Other Exchanges
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire 02-16-2021